View drug registration information details.


ItemsRegistration information
ID543
No543
Brand NameLOPID
IngredientsGEMFIBROZIL 300 MG
Dosage FormCAPSULE
Primary PackagingPVC-ALU BLISTER
StorageSTORE BELOW 30'C
Shelf Life60 MONTHS
Pack SizeBOX OF 10 X 10'S
Dispensing CategoryPrescription only
ATC ClassificationB04AC04
Pharmaceutical ClassLIPID MODIFYING
IndicationsGEMFIBROZIL IS A LIPID REGULATIONG AGENT THAT IS INDICATED FOR THE FOLLOWING : PRIMARY PREVENTION OF CORONARY HEART DISEASE (CHD) AND MYOCARDIAL INFARCTION (MI) IN PATIENTS WITH HYPERCHOLESTEROLEMIA, MIXED DYSLIPIDEMIA AND HYPERTRIGLYCERIDEMIA, FREDRICKSON'S CLASSIFICATION TYPES IIA, IIB AND IV.
ContraindicationsGEMFIBROZIL IS CONTRAINDICATED IN PATIENTS WITH HEPATIC OR SEVERE RENAL DYSFUNCTION
Side EffectsHEPATOBILIARY DISORDERS : CHLOESTATIC JAUNDICE
Unit PriceUSD 4.32 P
EDL Yes
DescriptionNO. 0 SNAP-FIT HARD GELATIN CAPSULES, WHITE OPAQUE BODY AND D-SCARLET OPAQUE CAP, BOVINE IMPRINTING-AXIAL ''PD 669'' AND ''LOPID TM'' IN GRAY CONTAINING A WHITE WAXY POWDER.
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerOLIC (THAILAND) LIMITED
CountryTHAILAND
Import Registration No1A 420/40
Import Registration Date1997-05-29
ActivityCERTIFICATE RELEASED
Applied Date2024-03-06
FDD Registration No07 I 4016/14
FDD Registration Date2024-06-22
Expiry Date2027-06-21

Back to drug list